GlaxoSmithKline and Vir Biotechnology Announced U.S. Gov’t Contracts to Purchase $1B of Sotrovimab for COVID-19
November 17, 2021
0
GlaxoSmithKline and Vir Biotechnology Announces US Gov't Contracts to Purchase Sotrovimab for COVID-19 GlaxoSmithKline plc (GSK) and Vir Biotechnology (